Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation FDAFDA announced major steps in its bold initiative to modernize the agency.Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) FDA FDA announced major steps in its bold initiative to modernize the agency. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineNext: Halozyme and Oruka sign agreement for Hypercon technology Related Stories Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026 Regulatory Outlook finally claims FDA approval for AMD drug pharminent July 27, 2026 Regulatory Outlook Therapeutics wins FDA approval for Lytenava in wet AMD pharminent July 27, 2026
